Teladoc Health, Inc. income statement TDOC

Annual Quarterly

In fiscal 2025, which ended Dec 31, 2025, Teladoc Health, Inc. reported revenue of $2.5 billion, down 1.5% from the year before. It recorded a net loss of $200.3 million. The operating loss came to $263.0 million, an operating margin of -10.4%. Diluted earnings per share were -$1.14. Over the twelve months ended Sep 30, 2026, revenue was $2.5 billion and the net loss was $154.8 million. Across the 10 fiscal years shown, revenue grew from $123.2 million in fiscal 2016 to $2.5 billion in fiscal 2025, about 39.9% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Sep 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019	FY 2018 Dec 31, 2018	FY 2017 Dec 31, 2017	FY 2016 Dec 31, 2016
Revenue	2,468 -2.4%	2,530 -1.5%	2,570 -1.3%	2,602 +8.1%	2,407 +18.4%	2,033 +85.8%	1,094 +97.7%	553 +32.4%	418 +79.1%	233 +89.4%	123 +59.2%
Cost of revenue	—	—	—	—	744 +14.4%	650 +66.4%	391 +111.9%	184 +43.3%	129 +108.9%	62 +92.7%	32 +51.9%
Gross profit	—	—	—	—	1,663 +20.3%	1,382 +96.6%	703 +90.6%	369 +27.6%	289 +68.5%	172 +88.2%	91 +61.8%
Research and development	268 -5.4%	278 -9.6%	307 -11.8%	349 +4.5%	334 +7.0%	312 +89.1%	165 +155.2%	65 +18.9%	54 +57.8%	34 +58.0%	22 +53.5%
Selling, general and administrative	620 -0.5%	626 -2.2%	640 -5.6%	678 +0.2%	677 -1.7%	689 +4.2%	661 +188.1%	229 +30.3%	176 +49.5%	118 +57.4%	75 +22.7%
Restructuring and impairment	—	19 -7.7%	20	—	—	—	—	—	1	—	—
Operating income	-163 +40.8%	-263 +74.2%	-1,021 -310.7%	-249 +98.2%	-13,653 -5039.9%	-266 +47.5%	-506 -529.5%	-80 -13.5%	-71 +6.0%	-75 -20.3%	-63 -12.3%
Interest income	27 -38.8%	37 -35.6%	57 +22.0%	47	—	—	—	—	—	—	—
Interest expense	20 -5.8%	20 -17.2%	24	—	—	—	—	—	—	—	—
Other non-operating income (expense)	-2 -186.6%	10 +271.8%	-6 -235.8%	4 +617.5%	-1 -116.9%	5	—	—	—	—	—
Pretax income	-159 +36.6%	-236 +76.3%	-994 -352.5%	-220 +98.4%	-13,663 -3452.1%	-385 +33.2%	-576 -426.2%	-109 -12.9%	-97 +9.4%	-107 -45.2%	-74 -27.1%
Income tax	-4 +85.6%	-35 -563.8%	8 +898.9%	1 +119.9%	-4 -108.6%	44 +148.6%	-91 -757.9%	-11 -9075.4%	0 +152.4%	-0 -144.1%	1 +1316.7%
Net income	-155 +30.8%	-200 +80.0%	-1,001 -354.4%	-220 +98.4%	-13,660 -3085.6%	-429 +11.6%	-485 -390.7%	-99 -1.8%	-97 +9.1%	-107 -43.9%	-74 -27.9%
Basic EPS	-0.86 +32.7%	-1.14 +80.6%	-5.87 -338.1%	-1.34 +98.4%	-84.60 -2998.9%	-2.73	—	—	—	—	—
Diluted EPS	-0.86 +32.7%	-1.14 +80.6%	-5.87 -338.1%	-1.34 +98.4%	-84.60 -2998.9%	-2.73	—	—	—	—	—
Weighted average shares, basic	180 +2.9%	176 +3.3%	171 +3.6%	165 +1.9%	161 +2.9%	157	—	—	—	—	—
Weighted average shares, diluted	180 +2.9%	176 +3.3%	171 +3.6%	165 +1.9%	161 +2.9%	157	—	—	—	—	—
Other measures
Depreciation and amortization	—	—	—	—	256 +25.4%	204 +193.9%	69 +95.2%	36	—	19 +130.9%	8 +70.1%
EBITDA	—	—	—	—	-13,397 -21722.4%	-61 +85.9%	-437 -874.4%	-45	—	-56 -3.5%	-54 -6.8%
Interest coverage	-8.00x	-13.34x	-42.89x	—	—	—	—	—	—	—	—
Margins
Gross margin	—	—	—	—	69.09%	68.01%	64.27%	66.66%	69.20%	73.58%	74.04%
Operating margin	-6.60%	-10.39%	-39.73%	-9.55%	-567.27%	-13.07%	-46.29%	-14.54%	-16.95%	-32.32%	-50.88%
Pretax margin	-6.43%	-9.31%	-38.67%	-8.44%	-567.69%	-18.92%	-52.65%	-19.78%	-23.20%	-45.87%	-59.85%
Profit margin	-6.27%	-7.92%	-38.97%	-8.47%	-567.53%	-21.09%	-44.35%	-17.87%	-23.23%	-45.77%	-60.26%
EBITDA margin	—	—	—	—	-556.63%	-3.02%	-39.94%	-8.10%	—	-24.13%	-44.17%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
Listed as: TDOC (NYSE)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: New York, NY
SEC filer status: Large accelerated filer
SEC CIK: 1477449
Former names: Teladoc, Inc. (until Aug 1, 2018)

Other Services-Offices & Clinics of Doctors of Medicine companies

All 12 Services-Offices & Clinics of Doctors of Medicine companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.